EUVIMEDEUVIMED entdecken
Crossref

Copper Increases the Sensitivity of Cholangiocarcinoma Cells to Tripterine by Inhibiting TMX2‐Mediated Unfolded Protein Reaction Activation

Hongwen Liu, Lei Xu, Yiyang Zhang, Yiqiong Xie, Lishan Wang, Yue Zhou, Zhangding Wang, Yani Pan, Wenying Li, Lu Xu, Xinyun Xu, Ting Wang und 7 weitere

Advanced Healthcare Materials · 2023

DOI: 10.1002/adhm.202300913 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Hongwen Liu und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province,…. Hauptthemen laut MEDLINE: Cholangiocarcinoma, Bile Duct Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy‐induced adaptive resistance is a significant factor that contributes to low therapeutic efficacy in tumor cells. The unfolded protein response (UPR) is a key mechanism in the development of drug resistance and serves as a critical reactive system for endoplasmic reticulum stress. Cu(II) can reduce the abundance of 60S ribosomal subunits and inhibit rRNA processing, leading to a decrease in the translation efficiency of the GRP78/BiP mRNA, which serves as a primary sensor for UPR activation. In this study, CuET‐Lipid@Cela, composed of CuET and tripterine (Cela), demonstrates a significant synergistic antitumor effect on cholangiocarcinoma (CCA) cells. RNA‐Seq is used to investigate the underlying mechanism, which suggests that the transmembrane protein 2 (TMX2) gene may be crucial in Cu(II) regulation of UPR by inhibiting the activation of GRP78/BiP and PERK/eIF2 α . The synergistic antitumor efficacy of CuET‐Lipid@Cela via inhibition of TMX2 is also confirmed in a myrAKT/YapS127A plasmid‐induced primary CCA mouse model, providing new insights into the reversal of acquired chemotherapy‐induced resistance in CCA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CholangiocarcinomaBile Duct NeoplasmsAntineoplastic AgentsAnimalsMiceCopperEndoplasmic Reticulum Chaperone BiPBile Ducts, IntrahepaticLipidsPentacyclic Triterpenes

Stichwörter der Autor:innen

Cu (II)TMX2chemotherapy resistancecholangiocarcinomamitochondrial dysfunctiontripterineunfolded protein reaction

Substanzen

CopperEndoplasmic Reticulum Chaperone BiPAntineoplastic AgentsLipidscelastrolPentacyclic Triterpenes

Autor:innen und Institutionen

  • Department of Gastroenterology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, 210008, P. R. China.
  • Department of Pharmacy, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, 21008, P. R. China.
  • Department of Gastroenterology, Nanjing Drum Tower Hospital Clinical College of Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, Jiangsu Province, 21008, P. R. China.
  • Department of Pathology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, 210008, P. R. China.
  • Department of Nuclear Medicine, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, 210008, P. R. China.
  • Department of Hepatopancreatobiliary Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, Jiangsu Province, 210008, P. R. China.

ORCID-Profile: Lei Wang

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Liu, H., Xu, L., Zhang, Y., Xie, Y., Wang, L., Zhou, Y., Wang, Z., Pan, Y., Li, W., Xu, L., Xu, X., Wang, T., Meng, K., He, J., Qiu, Y., Xu, G., Ge, W., Zhu, Y., & Wang, L. (2023). Copper Increases the Sensitivity of Cholangiocarcinoma Cells to Tripterine by Inhibiting TMX2‐Mediated Unfolded Protein Reaction Activation. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202300913

Vancouver

Liu H, Xu L, Zhang Y, Xie Y, Wang L, Zhou Y, et al. Copper Increases the Sensitivity of Cholangiocarcinoma Cells to Tripterine by Inhibiting TMX2‐Mediated Unfolded Protein Reaction Activation. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202300913

BibTeX
@article{Liu2023,
  author = {Liu, Hongwen and Xu, Lei and Zhang, Yiyang and Xie, Yiqiong and Wang, Lishan and Zhou, Yue and Wang, Zhangding and Pan, Yani and Li, Wenying and Xu, Lu and Xu, Xinyun and Wang, Ting and Meng, Kui and He, Jian and Qiu, Yudong and Xu, Guifang and Ge, Weihong and Zhu, Yun and Wang, Lei},
  title = {Copper Increases the Sensitivity of Cholangiocarcinoma Cells to Tripterine by Inhibiting TMX2‐Mediated Unfolded Protein Reaction Activation},
  journal = {Advanced Healthcare Materials},
  year = {2023},
  doi = {10.1002/adhm.202300913}
}
Kostenlos starten →